Highlights HANDOK Inc.

Equities

A002390

KR7002390003

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-23 EDT			5-day change	1st Jan Change
14,460 ^KRW	-0.69%		-1.97%	+1.12%

05-24	Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	MT
05-24	Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	05-24	MT
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	05-23	CI
Nxera Pharma Partners with Handok c. to Distribute PIVLAZ in South Korea,	04-15	MT
Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for Pivlaz in South Korea	04-14	CI
Sobi to Expand in South Korea via Rare Disease JV with Handok	02-13	MT
HANDOK Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
AUM Biosciences Enters in A Strategic Collaboration with Handok and CMG Pharm to Develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment	21-05-11	CI
An unknown buyer cancelled the acquisition of 2.7% stake in Genexine, Inc. from Handok Inc..	18-12-19	CI
An unknown buyer agreed to acquire 2.7% stake in Genexine, Inc. from Handok Inc. for KRW 27.3 billion.	17-12-20	CI
Institutional investors acquired 1.99% stake in Handok Inc. from Paean, Inc. for KRW 10 billion.	15-07-07	CI
Institutional investors acquired 2.38% stake in Handok Inc. from Paean, Inc. for KRW 9 billion.	15-04-27	CI
Handok Inc. cancelled the acquisition of an additional 16% stake in Genexine, Inc..	15-03-24	CI
An unknown buyer acquired additional 1.2% stake in Handok Inc. from Paean, Inc. for KRW 3.9 billion.	14-08-12	CI
Paean, Inc. sold 1.19% stake in Handok Inc. for KRW 3.7 billion.	14-08-01	CI
An unknown buyer acquired 0.4% stake in Handok Inc. from Paean, Inc. for KRW 1.2 billion.	14-08-01	CI
Handok Inc. agreed to acquire an additional 16% stake in Genexine, Inc. for KRW 25.8 billion.	14-03-24	CI
Handok Inc. completed the acquisition of partial asset of pharmaceutical business from Pacific Pharmaceutical Co., Ltd.	14-03-06	CI
Handok Inc. agreed to acquire partial asset of pharmaceutical business from Pacific Pharmaceutical Co., Ltd for KRW 57.5 billion.	13-12-12	CI
Teva Pharmaceutical Industries Limited Enters Agreement with Handok Pharmaceuticals Co., Ltd. to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market	12-12-16	CI
Teva Reportedly In Talks To Acquire Handok Pharmaceuticals	12-11-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HANDOK Inc.

Equities

A002390

KR7002390003

Highlights

Filters